Regencell Bioscience (RGC) has had the highest return this year by a US stock, returning 9,129%.

ASSET	YEAR	% RETURN
Regencell Bioscience (RGC)	2025	9,129.04%
CannBioRx Life Sciences (ATNFW)	2025	4,287.76%
DeFi Development (DFDV)	2025	2,513.32%
WW International, Inc Common Stock (WW)	2025	2,456.49%
Blue Gold Limited Warrant (BGLWW)	2025	2,063.5%
HCM II Acquisition (HONDW)	2025	2,046.55%
Triumph (TGI)	2025	1,462.98%
Oncology Institute (TOIIW)	2025	1,459.52%
Zepp Health (ZEPP)	2025	1,406.54%
Newegg Commerce (NEGG)	2025	1,283%
Diginex Limited Ordinary Shares (DGNX)	2025	1,207.51%
Oncology Institute (TOI)	2025	1,122.22%
CEA Industries (BNCWW)	2025	1,109.4%
CEA Industries (VAPEW)	2025	1,108.05%
K Wave Media (KWMWW)	2025	1,065.05%
Abivax SA American Depositary Shares (ABVX)	2025	892.96%
Webull Corporation Warrants (BULLW)	2025	882.2%
Cohen Circle Acquisition Corp I Warrant (CCIRW)	2025	867.45%
Anbio Biotechnology Class A Ordinary Shares (NNNN)	2025	861.03%
Ainos (AIMDW)	2025	833.27%
SRM Entertainment, Inc Common Stock (SRM)	2025	804.14%
Global Interactive Technologies (GITS)	2025	796.27%
CID HoldCo, Inc Warrants (DAICW)	2025	788%
Above Food Ingredients Inc Warrants (ABVEW)	2025	786.36%
Kindly MD, Inc Common Stock (KDLY)	2025	779.03%